On July 28, 2017, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, announced a comprehensive regulatory plan to expedite reducing the toll of more than 480 000 annual tobacco-related deaths in the United States.1 The plan is predicated on recognition that “nicotine—while highly addictive—is delivered through products that represent a continuum of risk and is most harmful when delivered through smoke particles in combustible cigarettes.”1
Warner KE, Schroeder SA. FDA’s Innovative Plan to Address the Enormous Toll of Smoking. JAMA. 2017;318(18):1755–1756. doi:10.1001/jama.2017.14336
Customize your JAMA Network experience by selecting one or more topics from the list below.